APA (7th ed.) Citation

Donglin Zhang, B., Kimberly Sable, M., Allison Miller, M., Molly Hinshaw, M., Timothy Schmidt, M., & Bridget E. Shields, M. (2023). Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin. Elsevier.

Chicago Style (17th ed.) Citation

Donglin Zhang, BA, MD Kimberly Sable, MD Allison Miller, MD Molly Hinshaw, MD Timothy Schmidt, and MD Bridget E. Shields. Granulomatous Variant of Scleromyxedema Successfully Treated with Topical Ruxolitinib, Dapsone and Intravenous Immunoglobulin. Elsevier, 2023.

MLA (9th ed.) Citation

Donglin Zhang, BA, et al. Granulomatous Variant of Scleromyxedema Successfully Treated with Topical Ruxolitinib, Dapsone and Intravenous Immunoglobulin. Elsevier, 2023.